Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1360-1365

  Gatzoulis, Konstantinos A ^a   Tsiachris, Dimitris ^a   Dilaveris, Polichronis ^a   Archontakis, Stefanos ^a   Arsenos, Petros ^a   Vouliotis, Apostolis ^a   Sideris, Skevos ^b   Trantalis, George ^b   Kartsagoulis, Efstathios ^a   Kallikazaros, Ioannis ^b   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Implantable cardioverter defibrillator; Left ventricular ejection fraction; Programmed ventricular stimulation

Indexed keywords

ADULT; AGED; ANTITACHYCARDIA PACING; ARTICLE; CARDIOVASCULAR MORTALITY; DEFIBRILLATION; DEVICE THERAPY; FAINTNESS; FEMALE; HEART DEATH; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PRESERVATION; HEART STIMULATION; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POST MYOCARDIAL INFARCTION; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; SUDDEN CARDIAC DEATH; TREATMENT DURATION;

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR EJECTION FRACTION; PROGRAMMED VENTRICULAR STIMULATION;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84881478601     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.005     Document Type: Article

References (28)

1. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities Heart Rhythm 5 2008 e1 e62
2. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
3. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
4. A.I. Mushlin, W.J. Hall, and J. Zwanziger The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial Circulation 97 1998 2129 2135
5. D.B. Mark, C.L. Nelson, and K.J. Anstrom Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Circulation 114 2006 135 142
6. P. Pascale, J. Schlaepfer, M. Oddo, M.D. Schaller, P. Vogt, and M. Fromer Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization Europace 11 2009 1639 1646
7. B. Uretsky, and G. Sheahan Primary prevention of sudden cardiac death in heart failure: will the result be shocking? J Am Coll Cardiol 30 1997 1589 1597
8. M. Luu, W.G. Stevenson, L.W. Stevenson, K. Baron, and J. Walden Diverse mechanisms of unexpected cardiac arrest in advanced heart failure Circulation 80 1989 1675 1680
9. E.C. Stecker, C. Vickers, and J. Waltz Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction. Two year findings from the Oregon Sudden Unexpected Death Study J Am Coll Cardiol 47 2006 1161 1166
10. S. Connolly, A.P. Hallstrom, and R. Cappato Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials Eur Heart J 21 2000 2071 2078
11. A.S. Manolis, P. Vardas, G. Sakantamis, K. Gatzoulis, and A.G. Manolis Guidelines for the implantation of cardiac defibrillators Hellenic J Cardiol 37 1996 165 171
12. M. Domanski, S. Saksena, and A. Epstein Relative effectiveness of the implantable cardioverter defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias J Am Coll Cardiol 34 1999 1090 1095
13. A.E. Buxton, K.L. Lee, and G.E. Hafley Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial Circulation 106 2002 2466 2472
14. A.E. Buxton, K.L. Lee, and G.E. Hafley Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study J Am Coll Cardiol 50 12 2007 1150 1157
15. D. Lloyd-Jones, R. Adams, and T. Brown Cardiovascular deaths and sudden death remain the single most common cause of death in the United States. Heart disease and stroke statistics-2010 update Circulation 121 2010 e1 e170
16. A.E. Buxton, K.E. Ellison, P. Lorvidhaya, and O. Ziv Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation J Cardiovasc Pharmacol 55 5 2010 450 455
17. P. Santangeli, A. Dello Russo, M. Casella, G. Pelargonio, L. Di Biase, and A. Natale Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe? Intern Med J 41 2011 55 60
18. A.P.M. Gorgels, C. Gijsbers, J. de Vreede-Swagemakers, A. Lousberg, and H.J. Wellens Out-of hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry Eur Heart J 24 2003 1204 1209
19. A. Bauer, P. Barthel, and R. Schneider Improved stratification of autonomic regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk) Eur Heart J 30 2009 576 583
20. F. Bokhari, D. Newman, M. Greene, V. Korley, I. Mangat, and P. Dorian Long-term comparison of the implantable cardioverter defibrillator vs amiodarone: 11 years follow up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS) Circulation 110 2004 112 116
21. J.L. Rouleau, M. Talajic, and B. Sussex Myocardial infarction patients in the 1990s - their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction Study J Am Coll Cardiol 27 1996 1119 1127
22. A.J. Moss, W.J. Hall, and D.S. Cannom Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933 1940
23. K. Gatzoulis, M. Salourou, and P. Dilaveris Programmed ventricular stimulation as a risk stratifier for the primary prevention of sudden cardiac death among dilated cardiomyopathy patients Eur Heart J 30 2009 693 (Abstract Suppl)
24. T. Ikeda, H. Yoshino, and K. Sugi Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study J Am Coll Cardiol 48 2006 2268 2274
25. K. Gatzoulis, M. Carlson, and L. Biblo Time domain analysis of the signal averaged electrocardiogram in patients with a conduction defect or a bundle branch block Eur Heart J 16 1995 1912 1919
26. M.R. Gold, D.M. Bloomfield, and K.P. Anderson A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification J Am Coll Cardiol 36 2000 2247 2253
27. P. Arsenos, K.A. Gatzoulis, and P. Dilaveris The rate-corrected QT interval calculated from 24-hour Holter recordings may serve as a significant arrhythmia risk stratifier in heart failure patients Int J Cardiol 147 2 2011 321 323
28. P. Arsenos, K. Gatzoulis, and G. Manis Decreased scale-specific heart rate variability after multiresolution wavelet analysis predicts sudden cardiac death in heart failure patients Int J Cardiol 154 3 2012 358 360